Matthias Pauthner
YOU?
Author Swipe
View article: Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study Open
Summary: Background: Lassa fever, caused by Lassa mammarenavirus (LASV), is a rodent-borne disease endemic to west Africa. Zoonotic surveillance of LASV provides epidemiological insights into its potential presence. We aimed to assess LASV…
View article: Continuous vital sign monitoring of acute Lassa fever using wearable biosensor devices in West Africa
Continuous vital sign monitoring of acute Lassa fever using wearable biosensor devices in West Africa Open
View article: Continuous vital sign monitoring of individuals with acute Lassa fever using wearable biosensor devices
Continuous vital sign monitoring of individuals with acute Lassa fever using wearable biosensor devices Open
Background Lassa fever is a fulminant viral illness associated with high in-hospital mortality. This disease constitutes a serious public health concern in West Africa, in particular Nigeria and the Mano River Union region (Guinea, Liberia…
View article: Priming antibody responses to the fusion peptide in rhesus macaques
Priming antibody responses to the fusion peptide in rhesus macaques Open
View article: Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever Open
View article: Focusing antibody responses to the fusion peptide in rhesus macaques
Focusing antibody responses to the fusion peptide in rhesus macaques Open
Immunodominance of antibodies targeting non-neutralizing epitopes and the high level of somatic hypermutation within germinal centers (GCs) required for most HIV broadly neutralizing antibodies (bnAbs) are major impediments to the developm…
View article: Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents
Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents Open
Background Lassa fever (LF) is a rodent-borne disease endemic to West Africa. In the absence of licensed therapeutics or vaccines, rodent exclusion from living spaces remains the primary method of preventing LF. Zoonotic surveillance of La…
View article: Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades Open
View article: Predicting the evolution of Lassa Virus endemic area and population at risk over the next decades
Predicting the evolution of Lassa Virus endemic area and population at risk over the next decades Open
Lassa fever is listed among the diseases that pose the greatest risks to public health by the World Health Organization. This severe viral hemorrhagic fever is caused by Lassa virus, a zoonotic pathogen that repeatedly spills over to human…
View article: A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus Open
View article: Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo
Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo Open
View article: Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease Open
During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV…
View article: Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome Open
Our results are relevant to HIV vaccine development efforts because they suggest that increasing the number of booster immunizations or delivering additional viral antigens may not necessarily improve vaccine efficacy against immunodeficie…
View article: Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques Open
View article: Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers
Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers Open
T follicular helper (TFH) cells are powerful regulators of affinity matured long-lived plasma cells. Eliciting protective, long-lasting antibody responses to achieve persistent immunity is the goal of most successful vaccines. T…
View article: HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite Open
Strain-specific autologous neutralizing antibodies may compete with N332 supersite targeting broadly neutralizing precursors.
View article: Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies Open
View article: Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits Open
A glycan hole is one of the most dominant autologous neutralizing epitopes targeted on BG505 and B41 SOSIP trimer-immunized rabbits. Our high-resolution cryo-electron microscopy (cryoEM) studies of B41 in complex with a B41-specific antibo…
View article: A Fc-Engineering Approach to Define Functional Humoral Correlates of Immunity Against Ebola Virus
A Fc-Engineering Approach to Define Functional Humoral Correlates of Immunity Against Ebola Virus Open
View article: Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques Open
View article: Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance Open
View article: Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques Open
View article: HIV Envelope Trimer-Elicited Autologous Neutralizing Antibodies Bind a Region Overlapping the N332 Glycan Supersite
HIV Envelope Trimer-Elicited Autologous Neutralizing Antibodies Bind a Region Overlapping the N332 Glycan Supersite Open
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit …
View article: Neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened
Neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened Open
Extensive studies with subtype A BG505-derived HIV envelope glycoprotein (Env) SOSIP immunogens have revealed that the dominant autologous neutralizing site in rabbits is located in an exposed region of the heavily glycosylated trimer that…
View article: A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge Open
View article: Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance Open
View article: The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template
The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template Open
View article: Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers Open
View article: Chimpanzee SIV Envelope trimer: structure and deployment as an HIV vaccine template
Chimpanzee SIV Envelope trimer: structure and deployment as an HIV vaccine template Open
Summary Epitope-targeted HIV vaccine design seeks to focus antibody responses to broadly neutralizing antibody (bnAb) sites by sequential immunization. Chimpanzee SIV Envelope (Env) shares a single bnAb site, the V2-apex, with HIV, suggest…
View article: Vaccine-induced protection from homologous Tier 2 simian-human immunodeficiency virus challenge in nonhuman primates
Vaccine-induced protection from homologous Tier 2 simian-human immunodeficiency virus challenge in nonhuman primates Open
SUMMARY Passive administration of HIV neutralizing antibodies (nAbs) can protect macaques from hard-to-neutralize (Tier 2) chimeric simian-human immunodeficiency virus (SHIV) challenge. However, conditions for nAb-mediated protection follo…